1. Home
  2. AUPH vs NVGS Comparison

AUPH vs NVGS Comparison

Compare AUPH & NVGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • NVGS
  • Stock Information
  • Founded
  • AUPH 1993
  • NVGS 1997
  • Country
  • AUPH Canada
  • NVGS United Kingdom
  • Employees
  • AUPH N/A
  • NVGS N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • NVGS Marine Transportation
  • Sector
  • AUPH Health Care
  • NVGS Consumer Discretionary
  • Exchange
  • AUPH Nasdaq
  • NVGS Nasdaq
  • Market Cap
  • AUPH 1.3B
  • NVGS 1.1B
  • IPO Year
  • AUPH 1999
  • NVGS N/A
  • Fundamental
  • Price
  • AUPH $9.50
  • NVGS $14.99
  • Analyst Decision
  • AUPH Strong Buy
  • NVGS Strong Buy
  • Analyst Count
  • AUPH 3
  • NVGS 3
  • Target Price
  • AUPH $10.33
  • NVGS $22.00
  • AVG Volume (30 Days)
  • AUPH 1.5M
  • NVGS 170.6K
  • Earning Date
  • AUPH 11-07-2024
  • NVGS 11-06-2024
  • Dividend Yield
  • AUPH N/A
  • NVGS 1.35%
  • EPS Growth
  • AUPH N/A
  • NVGS 13.48
  • EPS
  • AUPH N/A
  • NVGS 1.12
  • Revenue
  • AUPH $220,361,000.00
  • NVGS $564,280,000.00
  • Revenue This Year
  • AUPH $36.97
  • NVGS $0.14
  • Revenue Next Year
  • AUPH $16.43
  • NVGS $3.47
  • P/E Ratio
  • AUPH N/A
  • NVGS $13.39
  • Revenue Growth
  • AUPH 38.72
  • NVGS 5.99
  • 52 Week Low
  • AUPH $4.71
  • NVGS $14.47
  • 52 Week High
  • AUPH $10.67
  • NVGS $18.18
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 58.10
  • NVGS 39.30
  • Support Level
  • AUPH $9.22
  • NVGS $14.55
  • Resistance Level
  • AUPH $9.76
  • NVGS $15.56
  • Average True Range (ATR)
  • AUPH 0.42
  • NVGS 0.32
  • MACD
  • AUPH -0.02
  • NVGS -0.07
  • Stochastic Oscillator
  • AUPH 36.73
  • NVGS 37.30

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.

About NVGS Navigator Holdings Ltd. (Marshall Islands)

Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture).

Share on Social Networks: